Calm DOWN Little LADY! Comedian Pete Dominck Trying to Save Face After Scott...
VA Del. Nick Freitas Takes PANICKED, Anti-Trump Lefties APART in Write-Up Welcoming Them...
MSNBC Panelist: 1 Reason Dems Lost Is Because They Don't Have a Feminist...
Enjoy the L! Meet the Dozen or So Harpies Behind the KamalaHQ Account...
TRUMP 47 SALE: 74% Off VIP Membership - FINAL HOURS!
Guess Who Trump and Musk Are Meeting With Next Week (Big Gov't Lefties...
UPLIFTING: Bells of Notre Dame Ring for the First Time Since 2019 Fire
CBS Journo Explains Why Trump Didn't Have a Great Comeback and It's 'Too...
'BILLIONS and You Didn't WIN?!' Catfights Break OUT as Teams Biden and Harris...
THIS! Joe Rogan DEBUNKS Lefty's Conspiracy Theory About Trump and Russia in One...
OUCH! Axios Reminds Dems They 'Didn't Just Lose to Trump' (Count the Ways)
John Podhoretz Nukes Jennifer Rubin FROM ORBIT for Claiming Hitler Is LITERALLY in...
MSNBC Celebrates Beating CNN in Election Night Ratings (Guess Why So Many Were...
Oh HELL YEAH! Trump Shares EPIC, Kick-Butt, Super RAD 10-Step Plan to DISMANTLE...
Of ALL the Groups Kamala Lost, the 1 She BARELY Kept By 1...

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos